ZWJ Investment Counsel’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.7M Sell
89,795
-513
-0.6% -$190K 1.12% 33
2026
Q1
$26.4M Sell
90,308
-8,590
-9% -$2.82M 0.95% 43
2025
Q4
$34.7M Buy
98,898
+3,912
+4% +$1.32M 1.25% 29
2025
Q3
$30.7M Sell
94,986
-29,145
-23% -$9.06M 1.08% 39
2025
Q2
$48.3M Buy
124,131
+1,299
+1% +$522K 1.79% 23
2025
Q1
$53.4M Buy
122,832
+5,106
+4% +$2.05M 2.17% 16
2024
Q4
$43.4M Buy
117,726
+8,664
+8% +$3.63M 1.79% 21
2024
Q3
$56.7M Buy
109,062
+1,733
+2% +$926K 2.32% 9
2024
Q2
$58.2M Buy
107,329
+2,245
+2% +$1.19M 2.55% 8
2024
Q1
$54.5M Buy
105,084
+2,477
+2% +$1.23M 2.48% 8
2023
Q4
$48.4M Buy
102,607
+255
+0.2% +$118K 2.49% 9
2023
Q3
$44.6M Buy
+102,352
New +$46.4M 2.47% 10
2023
Q2
Sell
-95,142
Closed -$43.7M 205
2023
Q1
$43.7M Sell
95,142
-9,450
-9% -$4.5M 2.41% 9
2022
Q4
$53.7M Sell
104,592
-2,087
-2% -$1.06M 3.03% 3
2022
Q3
$48.5M Sell
106,679
-215
-0.2% -$103K 3.05% 2
2022
Q2
$51.6M Sell
106,894
-2,701
-2% -$1.34M 3.01% 2
2022
Q1
$53.8M Sell
109,595
-8,595
-7% -$3.93M 2.85% 5
2021
Q4
$54.8M Buy
+118,190
New +$49.7M 2.8% 6
2021
Q3
Sell
-119,906
Closed -$45.8M 183
2021
Q2
$45.8M Sell
119,906
-1,215
-1% -$464K 2.65% 6
2021
Q1
$43.5M Sell
121,121
-3,919
-3% -$1.26M 2.67% 7
2020
Q4
$40.1M Buy
125,040
+2,209
+2% +$678K 2.73% 7
2020
Q3
$33M Sell
122,831
-2,564
-2% -$690K 2.64% 8
2020
Q2
$33M Buy
125,395
+6,222
+5% +$1.66M 2.86% 8
2020
Q1
$27.1M Sell
119,173
-633
-0.5% -$173K 2.42% 13
2019
Q4
$36.2M Sell
119,806
-6,002
-5% -$1.65M 2.44% 8
2019
Q3
$30.2M Buy
125,808
+3,969
+3% +$1.09M 2.36% 12
2019
Q2
$34.4M Buy
121,839
+7,736
+7% +$2.11M 2.7% 5
2019
Q1
$32.7M Sell
114,103
-3,117
-3% -$901K 2.7% 7
2018
Q4
$30.8M Sell
117,220
-402
-0.3% -$111K 2.9% 7
2018
Q3
$32.2M Buy
117,622
+372
+0.3% +$96.6K 2.62% 7
2018
Q2
$27.9M Buy
117,250
+1,037
+0.9% +$240K 2.41% 12
2018
Q1
$25.5M Sell
116,213
-2,494
-2% -$586K 2.3% 13
2017
Q4
$26.7M Sell
118,707
-805
-0.7% -$171K 2.11% 12
2017
Q3
$22.7M Buy
119,512
+1,628
+1% +$310K 1.77% 23
2017
Q2
$22.2M Buy
117,884
+516
+0.4% +$92.7K 1.77% 19
2017
Q1
$19.4M Buy
117,368
+18,670
+19% +$2.97M 1.59% 24
2016
Q4
$14.2M Buy
98,698
+21,850
+28% +$2.93M 1.36% 33
2016
Q3
$9.63M Buy
76,848
+75,315
+4,913% +$9.72M 0.96% 45
2016
Q2
$201K Hold
1,533
0.02% 149
2016
Q1
$213K Buy
+1,533
New +$205K 0.02% 145

Other funds holding ELV

ZWJ Investment Counsel's ELV Position: Q2 2026 in Review

ZWJ Investment Counsel reduced its Elevance Health (ELV) stake by 0.57% in Q2 2026, selling an estimated $190K and leaving 89,795 shares worth $34.7M. The position accounts for 1.12% of the portfolio, ranked #33.

ZWJ Investment Counsel first reported a position in ELV in Q1 2016 and has held it in 40 quarters since. The position peaked at $58.2M in Q2 2024. 565 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • ZWJ Investment Counsel held 89,795 shares of Elevance Health worth $34.7M as of Q2 2026.
  • ZWJ Investment Counsel sold 513 Elevance Health shares in Q2 2026, an estimated $190K.
  • Elevance Health made up 1.12% of ZWJ Investment Counsel's portfolio in Q2 2026, its #33 holding.
  • ZWJ Investment Counsel first reported a position in Elevance Health in Q1 2016 and has held it in 40 quarters since.
  • ZWJ Investment Counsel's Elevance Health position peaked at $58.2M in Q2 2024.
  • 565 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on ZWJ Investment Counsel's 13F filing for Q2 2026, filed 16 Jul 2026.